antiprimod has been researched along with Multiple Myeloma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KC; Hamasaki, M; Hideshima, T; Ishitsuka, K; Jacob, GS; Kumar, S; Munshi, NC; Neri, P; Picker, DH; Raje, N; Richardson, PG; Shiraishi, N; Tassone, P; Yasui, H | 1 |
| Anderson, KC; Burger, R; Carrasco, DR; Catley, L; Fram, R; Goldmacher, VS; Jacob, GS; Munshi, NC; Munshi, V; Neri, P; Shammas, MA; Tassone, P; Venuta, S | 1 |
| Aggarwal, BB; Alexanian, R; Amit-Vazina, M; Estrov, Z; Harris, D; Shishodia, S; Talpaz, M; Van, Q; Wang, M; Weber, D | 1 |
| Anderson, KC; Batchu, RB; Blotta, S; Catley, L; Chauhan, D; Hamasaki, M; Hideshima, T; Jacob, GS; Munshi, NC; Neri, P; Picker, D; Prabhala, R; Schipani, E; Shammas, M; Tassone, P; Venuta, S; Yasui, H | 1 |
4 other study(ies) available for antiprimod and Multiple Myeloma
| Article | Year |
|---|---|
Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow; Cell Communication; Cell Proliferation; Drug Synergism; Endothelium, Vascular; Humans; Interleukin-6; Mice; Mice, SCID; Multiple Myeloma; Neovascularization, Physiologic; Signal Transduction; Spiro Compounds; Stromal Cells; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
A clinically relevant SCID-hu in vivo model of human multiple myeloma.
Topics: Animals; Bone Transplantation; Cell Line, Tumor; Dexamethasone; Disease Models, Animal; Fetal Tissue Transplantation; Green Fluorescent Proteins; Humans; Immunotoxins; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Receptors, Interleukin-6; Recombinant Proteins; Spiro Compounds; Transduction, Genetic; Transplantation, Heterologous | 2005 |
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.
Topics: Apoptosis; Blotting, Western; Caspases; Cell Cycle; Cell Line, Tumor; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; HIV Long Terminal Repeat; Humans; Multiple Myeloma; Phosphorylation; Spiro Compounds; STAT3 Transcription Factor; Trans-Activators | 2005 |
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Bone Resorption; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Metabolic Networks and Pathways; Mice; Mice, Nude; Mice, SCID; Multiple Myeloma; Neoplasm Proteins; Osteogenesis; Signal Transduction; Spiro Compounds; Xenograft Model Antitumor Assays | 2007 |